Pal-LCE-3C (55鈥?7)

General Information


DRACP ID  DRACP04129

Peptide Name   Pal-LCE-3C (55鈥?7)

Sequence  SHHRHFRSHQCRR

Sequence Length  13

UniProt ID  Q5T5A8 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C16

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C71H110N34O17S

Absent amino acids  ADEGIKLMNPTVWY

Common amino acids  HR

Mass  195814

Pl  12.5

Basic residues  8

Acidic residues  0

Hydrophobic residues  1

Net charge  8

Boman Index  -8640

Hydrophobicity  -235.38

Aliphatic Index  0

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30833614

Title  Cationic Intrinsically Disordered Antimicrobial Peptides (CIDAMPs) Represent a New Paradigm of Innate Defense with a Potential for Novel Anti-Infectives

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17457

DRACP is developed by Dr.Zheng's team.